| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |